Grafting for Alveolar Bone Loss

This trial tests a treatment called Ossix mineralized grafting to address bone loss in the jaw after tooth removal. The goal is to determine whether grafting immediately after tooth removal or later during implant placement better maintains bone height for successful dental implants. Individuals with at least 6 mm of bone height after tooth extraction and minimal surrounding damage may qualify. The trial seeks to reduce discomfort and improve outcomes for those needing dental implants. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance future dental implant procedures.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that the materials used in Ossix mineralized grafting are generally safe for patients. Studies have found that Ossix products, such as Ossix Plus and Ossix Agile, have received FDA approval and are frequently used in dental procedures. These materials are designed to be compatible with the body, meaning they integrate well and break down safely over time.

However, some important considerations exist. People allergic to collagen or materials derived from pigs should not use Ossix products. Although these allergies are rare, awareness is crucial.

Researchers are excited about the grafting treatments for alveolar bone loss because they utilize Ossix products, which are known for their advanced resorbable collagen membranes and bone graft materials. Unlike traditional grafting methods, these treatments use Ossix Plus and Ossix Agile, both FDA-approved and designed to integrate seamlessly with the body's natural healing processes. The Ossix products stand out for their ability to enhance bone regeneration while minimizing complications due to their resorbable nature, which means they gradually dissolve, eliminating the need for surgical removal. This innovative approach could lead to more efficient and comfortable recovery for patients undergoing dental procedures.

This trial will compare immediate grafting with delayed grafting using Ossix materials. Studies have shown that Ossix mineralized grafting effectively rebuilds jawbone, which is crucial for successful dental implants. Research indicates that Ossix products can result in an average of 43.8% new bone growth. More bone provides better support for dental implants. Additionally, case reports have demonstrated successful implant placements with strong tissue and bone support when using Ossix materials. Praised for their ease of shaping and stability, these materials aid in the reliable growth of new bone. Overall, research supports the use of Ossix grafting materials in dental procedures.¹⁴⁵⁶⁷